Navigation Links
EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Center's Selection of the OnCore Clinical Research Management System
Date:1/11/2011

MADISON, Wis., Jan. 12, 2011 /PRNewswire/ -- The University of Virginia (UVA) NCI-designated Cancer Center recently made the move from a comparatively sophisticated home-grown clinical trials management system (CTMS) to the OnCore Clinical Research Management System (OnCore-CRM) from Forte Research Systems, Inc.

(Logo:  http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

"We were using a home-grown system that included both Access and Web-based front ends. As a locally-designed system, it fit our workflow well in some ways and offered some modules that were comparable to the best commercial systems," said James H. Harrison, MD, PhD, Director of Biomedical Informatics at the UVA Cancer Center, who helped lead the project to enhance the Cancer Center's informatics infrastructure for clinical research.

While the existing system was good, it had grown incrementally for over 10 years with a number of developers, so aspects of its structure were awkward and difficult to maintain. The system lacked some capabilities of interest to the center such as a standards-based data representation, a unified user interface, and study financials management capabilities.

With the OnCore system, the UVA Cancer Center looks forward to reducing the amount of effort required to maintain their systems and eliminating the need for installed software on users' computers, which had previously caused version management issues. With OnCore, the Cancer Center will now be able to grant access to users via physically remote computers using a standard web browser over the Internet. OnCore also offers more options to be interoperable with other systems throughout the institution as well as with software provided by the NCI's caBIG program.

The choice to upgrade their clinical research informatics was part of a larger objective at the
'/>"/>

SOURCE Forte Research Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... announced today that it has acquired ... Inc. for $300 million. With the acquisition, Shire ... drops combining 0.6% povidone iodine (PVP-I) and 0.1% ... treatment of infectious conjunctivitis, an ocular surface condition ...
(Date:7/31/2015)... CHAPEL HILL, N.C. , July 31, 2015 ... to product success in the biopharmaceutical market. Patients ... the process of selecting and switching therapies. This ... and is pushing marketers, efforts toward patient-focused marketing. ... to patient engagement, marketers have learned it,s important ...
(Date:7/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report that provides an overview of syringes ... sourced from in-house databases, secondary and primary research. ... market products pipeline spread across 124 pages, talking ... tables and 5 figures is now available at ...
Breaking Medicine Technology:Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... Calif., Jan. 4, 2011 Intarcia Therapeutics, Inc. today ... will present at the 29th Annual JP Morgan Healthcare ... 2011 at the Westin St. Francis Hotel in San ... About Intarcia Intarcia Therapeutics, ...
... Pa., Jan. 4, 2011 Owner and medical director of ... her practice and is now offering Pixel Perfect™ ... CO2 laser from Alma Lasers. "I,m very ... Cirillo-Hyland said. "As a long time provider of aesthetic laser ...
Cached Medicine Technology:Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference 2Philadelphia's Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients 2
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... “Designing Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has ... with access to the tactics, techniques and practices required to design and develop ...
(Date:8/3/2015)... ... , ... A July 13 article from The Daily Mail titled "Jab ... That Can Last 'For Five Weeks'" discusses the use of stem cells to ... that harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... global insurance brokerage firm, announced today that Joe Williams has joined its growing ... sales, and delivering HUB's differentiated service model to his clients. Mr. Williams will ...
(Date:8/3/2015)... ... August 03, 2015 , ... Examination ... and investigative services, has introduced a new logo and comprehensive brand strategy ... improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. Improved ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, an online institution ... Association for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, Virginia, on ... the AHDI conference provides us to interact with those in the healthcare documentation ...
Breaking Medicine News(10 mins):Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2
... -- The death rate among children with severe malaria was ... artesunate than when they got the standard treatment of quinine, ... should replace quinine as the malaria treatment of choice for ... that is transmitted via the bite of an infected mosquito, ...
... 2010 Approximately 600,000 hysterectomies are performed in ... of the pelvis. More than two-thirds are performed ... statement published online today in The Journal ... medical specialty society of over 5,000 gynecologic surgeons, ...
... Thompson HealthDay Reporter , FRIDAY, Nov. 5 (HealthDay ... to rest as much as possible and avoid exertion, to ... But a growing number of physicians and researchers now say ... during treatment are more likely to beat cancer. The ...
... News) -- An international consortium of researchers has linked a ... increased risk for both autism spectrum disorders (ASD) and schizophrenia. ... an important role in the risk of both disorders, this ... specific abnormality, which takes the form of a wholesale absence ...
... This release is also available in Chinese on ... Thousands of the world,s top scientists and clinicians in the ... at the American Society of Human Genetics 60th Annual Meeting, which ... A number of scientific presentations at this year,s meeting will feature ...
... , FRIDAY, Nov. 5 (HealthDay News) -- New ... those who carry a particular gene mutation are particularly ... The apparent link between a specific variation of the ... is the first hard evidence to suggest that there ...
Cached Medicine News:Health News:New Malaria Drug Proves Effective in Study of African Children 2Health News:Most hysterectomies should be performed vaginally or laparoscopically 2Health News:To Best Fight Cancer, New Guidelines Urge Exercise 2Health News:To Best Fight Cancer, New Guidelines Urge Exercise 3Health News:To Best Fight Cancer, New Guidelines Urge Exercise 4Health News:Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia 2Health News:Studies validate use of family health history as gold standard in disease risk assessment 2Health News:Studies validate use of family health history as gold standard in disease risk assessment 3Health News:Studies validate use of family health history as gold standard in disease risk assessment 4Health News:Studies validate use of family health history as gold standard in disease risk assessment 5Health News:Studies validate use of family health history as gold standard in disease risk assessment 6Health News:Studies validate use of family health history as gold standard in disease risk assessment 7Health News:Studies validate use of family health history as gold standard in disease risk assessment 8Health News:Studies validate use of family health history as gold standard in disease risk assessment 9Health News:Studies validate use of family health history as gold standard in disease risk assessment 10Health News:Studies validate use of family health history as gold standard in disease risk assessment 11Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2
Extremely fine straight....
Curved delicate 5 mm blades....
Micro dressing forceps....
... The Leica M520 OH3 is ... best optical performance available on ... and unique stand. The Leica ... has the greatest range of ...
Medicine Products: